Tanner, Caroline M.

Parkinson disease

Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 5,415

Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology

Simon, D. K., Tanner, C. M., & Brundin, P. (2020) · Clinics in Geriatric Medicine

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 1,114

The epidemiology of Parkinson's disease

Ben-Shlomo, Y., Darweesh, S., Llibre-Guerra, J., Marras, C., San Luciano, M., & Tanner, C. (2024) · The Lancet

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 967

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsNeurology and Historical Studies

Cited by 859

Frequency of Bowel Movements and the Future Risk of Parkinson’s Disease

Abbott, R. D., Petrovitch, H., White, L. R., Masaki, K. H., Tanner, C. M., Curb, J. D., Grandinetti, A., Blanchette, P. L., Popper, J. S., & Ross, G. W. (2001) · Neurology

Parkinson's Disease Mechanisms and TreatmentsGastrointestinal motility and disorders

Cited by 839

Current and projected future economic burden of Parkinson’s disease in the U.S.

Yang, W., Hamilton, J. L., Kopil, C., Beck, J. C., Tanner, C. M., Albin, R. L., Ray Dorsey, E., Dahodwala, N., Cintina, I., Hogan, P., et al. (2020) · npj Parkinson's Disease

Parkinson's Disease Mechanisms and TreatmentsHealth Systems, Economic Evaluations, Quality of Life

Cited by 657

Epidemiology of parkinson’s disease

Tanner, C. M., & Goldman, S. M. (1996) · Neurologic Clinics

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 640

DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers

Lippa, C. F., Duda, J. E., Grossman, M., Hurtig, H. I., Aarsland, D., Boeve, B. F., Brooks, D. J., Dickson, D. W., Dubois, B., Emre, M., et al. (2007) · Neurology

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 548

Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson’s disease

Do, C. B., Tung, J. Y., Dorfman, E., Kiefer, A. K., Drabant, E. M., Francke, U., Mountain, J. L., Goldman, S. M., Tanner, C. M., Langston, J. W., et al. (2011) · PLoS Genetics

Parkinson's Disease Mechanisms and TreatmentsGenetic Associations and Epidemiology

Cited by 515

Incidence of Parkinson disease in North America

Willis, A. W., Roberts, E., Beck, J. C., Fiske, B., Ross, W., Savica, R., Van Den Eeden, S. K., Tanner, C. M., Marras, C., on behalf of the Parkinson’s Foundation P4 Group, et al. (2022) · npj Parkinson's Disease

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 341

Head injury and Parkinson's disease risk in twins

Goldman, S. M., Tanner, C. M., Oakes, D., Bhudhikanok, G. S., Gupta, A., & Langston, J. W. (2006) · Annals of Neurology

Parkinson's Disease Mechanisms and TreatmentsTraumatic Brain Injury Research

Cited by 297

Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases

Espay, A. J., Vizcarra, J. A., Marsili, L., Lang, A. E., Simon, D. K., Merola, A., Josephs, K. A., Fasano, A., Morgante, F., Savica, R., et al. (2019) · Neurology

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Cited by 274

A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor

Brin, M. F., Lyons, K. E., Doucette, J., Adler, C. H., Caviness, J. N., Comella, C. L., Dubinsky, R. M., Friedman, J. H., Manyam, B. V., Matsumoto, J. Y., et al. (2001) · Neurology

Botulinum Toxin and Related Neurological DisordersDeep Brain Stimulation and Movement Disorders

Cited by 233

Quality of life in essential tremor questionnaire (QUEST): development and initial validation

Tröster, A. I., Pahwa, R., Fields, J. A., Tanner, C. M., & Lyons, K. E. (2005) · Parkinsonism & Related Disorders

Deep Brain Stimulation and Movement DisordersBotulinum Toxin and Related Neurological Disorders

Cited by 217

The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease

Brown, E. G., Chahine, L. M., Goldman, S. M., Korell, M., Mann, E., Kinel, D. R., Arnedo, V., Marek, K. L., & Tanner, C. M. (2020) · Journal of Parkinson's Disease

Parkinson's Disease Mechanisms and TreatmentsCOVID-19 and healthcare impacts

Cited by 177

Nicotine and Parkinson's disease: implications for therapy

Quik, M., O'Leary, K., & Tanner, C. M. (2008) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsNicotinic Acetylcholine Receptors Study

Cited by 154

Dietary fat intake, pesticide use, and Parkinson's disease

Kamel, F., Goldman, S. M., Umbach, D. M., Chen, H., Richardson, G., Barber, M. R., Meng, C., Marras, C., Korell, M., Kasten, M., et al. (2014) · Parkinsonism & Related Disorders

Parkinson's Disease Mechanisms and TreatmentsFatty Acid Research and Health

Cited by 127

Benefits and Risks of Pharmacological Treatments for Essential Tremor

Lyons, K. E., Pahwa, R., Comella, C. L., Eisa, M. S., Elble, R. J., Fahn, S., Jankovic, J., Juncos, J. L., Koller, W. C., Ondo, W. G., et al. (2003) · Drug Safety

Deep Brain Stimulation and Movement DisordersBotulinum Toxin and Related Neurological Disorders

Cited by 103

Associations of ozone and PM2. 5 concentrations with Parkinson's disease among participants in the agricultural health study

Kirrane, E. F., Bowman, C., Davis, J. A., Hoppin, J. A., Blair, A., Chen, H., Patel, M. M., Sandler, D. P., Tanner, C. M., Vinikoor-Imler, L., et al. (2015) · Journal of Occupational & Environmental Medicine

Air Quality and Health ImpactsParkinson's Disease Mechanisms and Treatments

Cited by 100

Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study

Adams, J. L., Kangarloo, T., Tracey, B., O’Donnell, P., Volfson, D., Latzman, R. D., Zach, N., Alexander, R., Bergethon, P., Cosman, J., et al. (2023) · npj Parkinson's Disease

Parkinson's Disease Mechanisms and TreatmentsContext-Aware Activity Recognition Systems

Cited by 98

Research on the Premotor Symptoms of Parkinson’s Disease: Clinical and Etiological Implications

Chen, H., Burton, E. A., Ross, G. W., Huang, X., Savica, R., Abbott, R. D., Ascherio, A., Caviness, J. N., Gao, X., Gray, K. A., et al. (2013) · Environmental Health Perspectives

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 83

Parkinson’s progression markers initiative: a milestone-based strategy to monitor Parkinson’s disease progression

Brumm, M. C., Siderowf, A., Simuni, T., Burghardt, E., Choi, S. H., Caspell-Garcia, C., Chahine, L. M., Mollenhauer, B., Foroud, T., Galasko, D., et al. (2023) · Journal of Parkinson’s Disease

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 70